bioAffinity Technologies (BIAF) Capital Expenditures Growth (1y) (2024 - 2026)
bioAffinity Technologies (BIAF) Capital Expenditures Growth (1y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 50.00% |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 3.87% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | -3.27% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | -72.44% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | -33.33% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | -10.56% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | 1.48% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 18.75% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | 0.92% |
| 10 | bioAffinity Technologies | 2.04 Mn | -1.06 Mn | - | -88.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -88.85% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | -138.75% |
| Jun 30, 2025 | -52.53% |
| Mar 31, 2025 | 22.71% |
| Dec 31, 2024 | 100.01% |
| Sep 30, 2024 | 5,468.05% |
| Jun 30, 2024 | 632.58% |
| Mar 31, 2024 | 28.08% |